517 related articles for article (PubMed ID: 8853518)
1. Bone remodeling, normal and abnormal: a biological basis for the understanding of cancer-related bone disease and its treatment.
Parfitt AM
Can J Oncol; 1995 Dec; 5 Suppl 1():1-10. PubMed ID: 8853518
[TBL] [Abstract][Full Text] [Related]
2. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone.
Parfitt AM
J Cell Biochem; 1994 Jul; 55(3):273-86. PubMed ID: 7962158
[TBL] [Abstract][Full Text] [Related]
3. Osteoclast-derived activity in the coupling of bone formation to resorption.
Martin TJ; Sims NA
Trends Mol Med; 2005 Feb; 11(2):76-81. PubMed ID: 15694870
[TBL] [Abstract][Full Text] [Related]
4. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.
Seeman E
Osteoporos Int; 2003; 14 Suppl 3():S2-8. PubMed ID: 12730770
[TBL] [Abstract][Full Text] [Related]
5. Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances.
Huffer WE
Lab Invest; 1988 Oct; 59(4):418-42. PubMed ID: 3050272
[TBL] [Abstract][Full Text] [Related]
6. Biology of the basic multicellular unit and the pathophysiology of osteoporosis.
Jilka RL
Med Pediatr Oncol; 2003 Sep; 41(3):182-5. PubMed ID: 12868116
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone temporal effects on bone formation and resorption.
Kroll MH
Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
[TBL] [Abstract][Full Text] [Related]
8. Bone remodeling.
Hadjidakis DJ; Androulakis II
Ann N Y Acad Sci; 2006 Dec; 1092():385-96. PubMed ID: 17308163
[TBL] [Abstract][Full Text] [Related]
9. Physiopathological basis of bone turnover.
Masi L; Brandi ML
Q J Nucl Med; 2001 Mar; 45(1):2-6. PubMed ID: 11456372
[TBL] [Abstract][Full Text] [Related]
10. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
Christiansen P
APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast-osteoblast communication.
Matsuo K; Irie N
Arch Biochem Biophys; 2008 May; 473(2):201-9. PubMed ID: 18406338
[TBL] [Abstract][Full Text] [Related]
12. [The cytokines that maintain living bone].
Riancho JA; Zarrabeitia MT; González Macías J
Med Clin (Barc); 1992 Jun; 99(3):110-5. PubMed ID: 1630198
[No Abstract] [Full Text] [Related]
13. [Bone tissue and cancer].
Rossi JF
Pathol Biol (Paris); 1990 Jan; 38(1):69-79. PubMed ID: 2407992
[TBL] [Abstract][Full Text] [Related]
14. [How is bone formed and resorbed?-- molecular mechanisms of bone formation and resorption].
Suda T
Rinsho Byori; 2002 Mar; 50(3):267-72. PubMed ID: 11985054
[TBL] [Abstract][Full Text] [Related]
15. [Bone remodelling and its regulators].
Yoshikawa H; Takaoka K
Nihon Rinsho; 1994 Sep; 52(9):2262-7. PubMed ID: 7967065
[TBL] [Abstract][Full Text] [Related]
16. How the osteoclast degrades bone.
Blair HC
Bioessays; 1998 Oct; 20(10):837-46. PubMed ID: 9819571
[TBL] [Abstract][Full Text] [Related]
17. [Development, physiology, and cell activity of bone].
de Baat P; Heijboer MP; de Baat C
Ned Tijdschr Tandheelkd; 2005 Jul; 112(7):258-63. PubMed ID: 16047964
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
19. Regulation of apoptosis in osteoclasts and osteoblastic cells.
Xing L; Boyce BF
Biochem Biophys Res Commun; 2005 Mar; 328(3):709-20. PubMed ID: 15694405
[TBL] [Abstract][Full Text] [Related]
20. Bone cell interactions and regulation by inflammatory mediators.
Oates TW; Cochran DL
Curr Opin Periodontol; 1996; 3():34-44. PubMed ID: 8624568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
